{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T07:56:54Z","timestamp":1771660614642,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T00:00:00Z","timestamp":1634342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T00:00:00Z","timestamp":1634342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000060","name":"national institute of allergy and infectious diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006955","name":"office of extramural research, national institutes of health","doi-asserted-by":"publisher","award":["T32 GM007170"],"award-info":[{"award-number":["T32 GM007170"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s10875-021-01137-w","type":"journal-article","created":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T16:51:24Z","timestamp":1634403084000},"page":"108-118","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["A Double-Blind, Placebo-Controlled, Crossover Study of Magnesium Supplementation in Patients with XMEN Disease"],"prefix":"10.1007","volume":"42","author":[{"given":"Samuel D.","family":"Chauvin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Price","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Hunsberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Brofferio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgan","family":"Similuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio D.","family":"Rosenzweig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen C.","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey I.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Lenardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan C.","family":"Ravell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,16]]},"reference":[{"issue":"5","key":"1137_CR1","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s10875-020-00790-x","volume":"40","author":"JC Ravell","year":"2020","unstructured":"Ravell JC, Chauvin SD, He T, Lenardo M. An update on XMEN Disease. J Clin Immunol. 2020;40(5):671\u201381.","journal-title":"J Clin Immunol"},{"key":"1137_CR2","doi-asserted-by":"publisher","unstructured":"Li F-Y, Chaigne-Delalande B, Kanellopoulou C, Davis JC, Matthews HF, Douek DC, et al. Second messenger role for Mg2+ revealed by human T-cell immunodeficiency. Nature [Internet]. 2011;475(7357):471\u20136.\u00a0https:\/\/doi.org\/10.1038\/nature10246.","DOI":"10.1038\/nature10246"},{"key":"1137_CR3","doi-asserted-by":"crossref","unstructured":"Blommaert E, P\u00e9anne R, Cherepanova NA, Rymen D, Staels F, Jaeken J, et al. Mutations in MAGT1 lead to a glycosylation disorder with a variable phenotype. Proc Natl Acad Sci [Internet].\u00a02019;116(20):9865 LP \u2013 9870.\u00a0Available from:\u00a0http:\/\/www.pnas.org\/content\/116\/20\/9865.abstract. Accessed 1 June 2021.","DOI":"10.1073\/pnas.1817815116"},{"key":"1137_CR4","doi-asserted-by":"publisher","unstructured":"Klinken EM, Gray PE, Pillay B, Worley L, Edwards ESJ, Payne K, et al. Diversity of XMEN disease: description of 2 novel variants and analysis of the lymphocyte phenotype. J Clin Immunol [Internet]. 2020;40(2):299\u2013309. https:\/\/doi.org\/10.1007\/s10875-019-00732-2.","DOI":"10.1007\/s10875-019-00732-2"},{"issue":"1","key":"1137_CR5","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1172\/JCI131116","volume":"130","author":"JC Ravell","year":"2020","unstructured":"Ravell JC, Matsuda-Lennikov M, Chauvin SD, Zou J, Biancalana M, Deeb SJ, et al. Defective glycosylation and multisystem abnormalities characterize the primary immunodeficiency XMEN disease. J Clin Invest. 2020;130(1):507\u201322.","journal-title":"J Clin Invest"},{"issue":"37","key":"1137_CR6","doi-asserted-by":"publisher","first-page":"13638","DOI":"10.1074\/jbc.RA119.008903","volume":"294","author":"M Matsuda-Lennikov","year":"2019","unstructured":"Matsuda-Lennikov M, Biancalana M, Zou J, Ravell JC, Zheng L, Kanellopoulou C, et al. Magnesium transporter 1 (MAGT1) deficiency causes selective defects in N-linked glycosylation and expression of immune-response genes. J Biol Chem. 2019;294(37):13638\u201356.","journal-title":"J Biol Chem"},{"issue":"6142","key":"1137_CR7","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1126\/science.1240094","volume":"341","author":"B Chaigne-Delalande","year":"2013","unstructured":"Chaigne-Delalande B, Li F-Y, O\u2019Connor GM, Lukacs MJ, Jiang P, Zheng L, et al. Mg2+ regulates cytotoxic functions of NK and CD8 T cells in chronic EBV infection through NKG2D. Science. 2013;341(6142):186\u201391.","journal-title":"Science"},{"issue":"14","key":"1137_CR8","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1182\/blood-2013-11-538686","volume":"123","author":"F-Y Li","year":"2014","unstructured":"Li F-Y, Chaigne-Delalande B, Su H, Uzel G, Matthews H, Lenardo MJ. XMEN disease: a new primary immunodeficiency affecting Mg2+ regulation of immunity against Epstein-Barr virus. Blood. 2014;123(14):2148\u201352.","journal-title":"Blood"},{"issue":"1","key":"1137_CR9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1084\/jem.20160849","volume":"214","author":"H Abolhassani","year":"2017","unstructured":"Abolhassani H, Edwards ESJ, Ikinciogullari A, Jing H, Borte S, Buggert M, et al. Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency. J Exp Med. 2017;214(1):91\u2013106.","journal-title":"J Exp Med"},{"issue":"1","key":"1137_CR10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1084\/jem.20160784","volume":"214","author":"K Izawa","year":"2017","unstructured":"Izawa K, Martin E, Soudais C, Bruneau J, Boutboul D, Rodriguez R, et al. Inherited CD70 deficiency in humans reveals a critical role for the CD70-CD27 pathway in immunity to Epstein-Barr virus infection. J Exp Med. 2017;214(1):73\u201389.","journal-title":"J Exp Med"},{"key":"1137_CR11","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.3389\/fimmu.2017.02015","volume":"8","author":"R Caorsi","year":"2017","unstructured":"Caorsi R, Rusmini M, Volpi S, Chiesa S, Pastorino C, Sementa AR, et al. CD70 Deficiency due to a novel mutation in a patient with severe chronic EBV infection presenting as a periodic fever. Front Immunol. 2017;8:2015.","journal-title":"Front Immunol"},{"key":"1137_CR12","doi-asserted-by":"crossref","unstructured":"Kanellopoulou C, George AB, Masutani E, Cannons JL, Ravell JC, Yamamoto TN, et al. Mg(2+) regulation of kinase signaling and immune function. J Exp Med [Internet].\u00a02019;216(8):1828\u201342.\u00a0Available from:\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/31196981.\u00a0Accessed 1 July 2021.","DOI":"10.1084\/jem.20181970"},{"key":"1137_CR13","doi-asserted-by":"crossref","unstructured":"Ram\u00edrez AS, Kowal J, Locher KP. Cryo\u2013electron microscopy structures of human oligosaccharyltransferase complexes OST-A and OST-B. Science (80- ) [Internet].\u00a02019;366(6471):1372 LP \u2013 1375.\u00a0Available from:\u00a0http:\/\/science.sciencemag.org\/content\/366\/6471\/1372.abstract. Accessed 1 July 2021.","DOI":"10.1126\/science.aaz3505"},{"issue":"4","key":"1137_CR14","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1083\/jcb.201404083","volume":"206","author":"NA Cherepanova","year":"2014","unstructured":"Cherepanova NA, Shrimal S, Gilmore R. Oxidoreductase activity is necessary for N-glycosylation of cysteine-proximal acceptor sites in glycoproteins. J Cell Biol. 2014;206(4):525\u201339.","journal-title":"J Cell Biol"},{"key":"1137_CR15","doi-asserted-by":"crossref","unstructured":"Ondruskova N, Cechova A, Hansikova H, Honzik T, Jaeken J. Congenital disorders of glycosylation: still \u201chot\u201d in 2020. Biochim Biophys Acta - Gen Subj [Internet]. 2021;1865(1):129751.\u00a0Available from:\u00a0https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0304416520302622.\u00a0Accessed 1 June 2021.","DOI":"10.1016\/j.bbagen.2020.129751"},{"issue":"3","key":"1137_CR16","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/clinchem\/47.3.513","volume":"47","author":"JM Lacey","year":"2001","unstructured":"Lacey JM, Bergen HR, Magera MJ, Naylor S, O\u2019Brien JF. Rapid determination of transferrin isoforms by immunoaffinity liquid chromatography and electrospray mass spectrometry. Clin Chem. 2001;47(3):513\u20138.","journal-title":"Clin Chem"},{"issue":"2","key":"1137_CR17","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1037\/a0029146","volume":"142","author":"JK Kruschke","year":"2013","unstructured":"Kruschke JK. Bayesian estimation supersedes the t test. J Exp Psychol Gen. 2013;142(2):573\u2013603.","journal-title":"J Exp Psychol Gen"},{"issue":"Suppl 2","key":"1137_CR18","first-page":"382","volume":"3","author":"C Harms","year":"2018","unstructured":"Harms C, Lakens D. Making, \u201cnull effects\u201d informative: statistical techniques and inferential frameworks. J Clin Transl Res. 2018;3(Suppl 2):382\u201393.","journal-title":"J Clin Transl Res"},{"issue":"7","key":"1137_CR19","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1086\/605610","volume":"200","author":"H Kimura","year":"2009","unstructured":"Kimura H, Miyake K, Yamauchi Y, Nishiyama K, Iwata S, Iwatsuki K, et al. Identification of Epstein-Barr virus (EBV)-infected lymphocyte subtypes by flow cytometric in situ hybridization in EBV-associated lymphoproliferative diseases. J Infect Dis. 2009;200(7):1078\u201387.","journal-title":"J Infect Dis"},{"issue":"8","key":"1137_CR20","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1111\/j.1349-7006.2012.02305.x","volume":"103","author":"S Kawabe","year":"2012","unstructured":"Kawabe S, Ito Y, Gotoh K, Kojima S, Matsumoto K, Kinoshita T, et al. Application of flow cytometric in situ hybridization assay to Epstein-Barr virus-associated T\/natural killer cell lymphoproliferative diseases. Cancer Sci. 2012;103(8):1481\u20138.","journal-title":"Cancer Sci"},{"issue":"6","key":"1137_CR21","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1056\/NEJMoa1206605","volume":"370","author":"LC Tegtmeyer","year":"2014","unstructured":"Tegtmeyer LC, Rust S, van Scherpenzeel M, Ng BG, Losfeld M-E, Timal S, et al. Multiple phenotypes in phosphoglucomutase 1 deficiency. N Engl J Med. 2014;370(6):533\u201342.","journal-title":"N Engl J Med"},{"issue":"5","key":"1137_CR22","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1203\/00006450-200211000-00003","volume":"52","author":"S Grunewald","year":"2002","unstructured":"Grunewald S, Matthijs G, Jaeken J. Congenital disorders of glycosylation: a review. Pediatr Res. 2002;52(5):618\u201324.","journal-title":"Pediatr Res"},{"key":"1137_CR23","unstructured":"Common Terminology Criteria for Adverse Events [Internet]. NCI CTEP. 2010.\u00a0Available from: https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm.\u00a0Accessed 1 June 2021."},{"key":"1137_CR24","doi-asserted-by":"crossref","unstructured":"Brault J, Meis RJ, Li L, Bello E, Liu T, Sweeney CL, et al. MAGT1 messenger RNA-corrected autologous T and natural killer cells for potential cell therapy in X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia disease. Cytotherapy [Internet]. 2021;23(3):203\u201310.\u00a0Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1465324920308525.\u00a0Accessed 1 June 2021.","DOI":"10.1016\/j.jcyt.2020.08.013"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-021-01137-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-021-01137-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-021-01137-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T10:21:23Z","timestamp":1644229283000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-021-01137-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,16]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["1137"],"URL":"https:\/\/doi.org\/10.1007\/s10875-021-01137-w","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,16]]},"assertion":[{"value":"27 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study followed the principles of the Declaration of Helsinki, the International Conference on Harmonization (ICH)-Good Clinical Practice (GCP) guidelines, and the National Institute of Allergy and Infectious Diseases (NIAID) guidelines. This trial is registered at the US National Institutes of Health (ClinicalTrials.gov) #NCT02496676.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All patients or their legal representatives provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}